跳至主要内容
临床试验/NCT00538044
NCT00538044Unknown1 期

the Clinical Research Using Simvastatin as a Medication to Treat Advanced Secondary Pulmonary Hypertension

Capital Medical University1 个研究点 分布在 1 个国家开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
试验地点
1
主要终点
the simvastatin can alleviate pulmonary hypertension

研究概览

简要总结

we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

详细描述

advanced pulmonary hypertension is refractory to the medication in use nowaday, especially pulmonary hypertension secondary to congenital heart disease or chronic pulmonary embolism.It is revealed that statins may intefere the pathogenisis of the pulmonary hypertension in many key poing, such as improving apotosis or inhiting the proliferation of pulmonary vascular smooth muscle cell. so we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
12 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pasp>50mmHg

排除标准

  • pasp<50mmhg

研究组 & 干预措施

1simvastatin group

Experimental

before the operation, the patient start the simvastatin medication on the dosage of 40mg per day

干预措施: simvastatin (Drug)

结局指标

主要结局

the simvastatin can alleviate pulmonary hypertension

pulmonary pressure

次要结局

  • simvastatin can highten the perioperative and long term survaval rate and the living quality

研究者

发起方
Capital Medical University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验